Polymer manufacturer for the medical industry Gwalia Healthcare has announced a continued investment for its cleanroom capabilities.
Clinical setting
The South Wales company has recently completed the first stage of its cleanroom development and has now started stages two and three.
Gwalia Healthcare has finished the development of two ESD class 7, controlled environment areas dedicated to both injection moulding and medical device and component assembly.
The company now has plans to begin stage two and three, which will help it focus on production, R&D and the development of medical devices for clinical trials.
All the cleanrooms include new ERP systems to deliver fill control and traceability for all components and assemblies.
The development of the new cleanrooms have been in response to Gwalia Healthcare’s growing medical devices business which sits alongside its packaging work for medicines.
Speaking about the investment, Rod Parker, CEO of Gwalia Healthcare, said: “For some years now we have been de-commodifying our product range and an increase in high quality high value precision devices is a logical next step.”